ID   DYH17_HUMAN             Reviewed;        4462 AA.
AC   Q9UFH2; O00431; O15206; Q2M2Y1; Q6ZRQ2; Q8N7Q7;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-SEP-2018, sequence version 3.
DT   28-JUN-2023, entry version 145.
DE   RecName: Full=Dynein axonemal heavy chain 17 {ECO:0000305};
DE   AltName: Full=Axonemal beta dynein heavy chain 17;
DE   AltName: Full=Axonemal dynein heavy chain-like protein 1;
DE   AltName: Full=Ciliary dynein heavy chain 17;
DE   AltName: Full=Ciliary dynein heavy chain-like protein 1;
DE   AltName: Full=Dynein axonemal light chain 2;
GN   Name=DNAH17 {ECO:0000312|HGNC:HGNC:2946}; Synonyms=DNAHL1, DNEL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 264-4462 (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 278-4462 (ISOFORM 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1852-1952 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=9373155; DOI=10.1016/s0378-1119(97)00417-4;
RA   Neesen J., Koehler M.R., Kirschner R., Steinlein C., Kreutzberger J.,
RA   Engel W., Schmid M.;
RT   "Identification of dynein heavy chain genes expressed in human and mouse
RT   testis: chromosomal localization of an axonemal dynein gene.";
RL   Gene 200:193-202(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3185-4462 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3284-4462 (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=9545504; DOI=10.1007/s003359900782;
RA   Milisav I., Affara N.A.;
RT   "A potential human axonemal dynein heavy-chain gene maps to 17q25.";
RL   Mamm. Genome 9:404-407(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   INVOLVEMENT IN SPGF39, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, VARIANTS
RP   SPGF39 431-TYR--VAL-4462 DEL; TYR-1829; LEU-ASP-PRO-VAL-3496 INS; LEU-3499
RP   AND PRO-3595, CHARACTERIZATION OF VARIANTS SPGF39 TYR-1829;
RP   LEU-ASP-PRO-VAL-3496 INS; LEU-3499 AND PRO-3595, AND DEVELOPMENTAL STAGE.
RX   PubMed=31178125; DOI=10.1016/j.ajhg.2019.04.015;
RA   Whitfield M., Thomas L., Bequignon E., Schmitt A., Stouvenel L.,
RA   Montantin G., Tissier S., Duquesnoy P., Copin B., Chantot S., Dastot F.,
RA   Faucon C., Barbotin A.L., Loyens A., Siffroi J.P., Papon J.F., Escudier E.,
RA   Amselem S., Mitchell V., Toure A., Legendre M.;
RT   "Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm
RT   Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.";
RL   Am. J. Hum. Genet. 105:198-212(2019).
CC   -!- FUNCTION: Force generating protein component of the outer dynein arms
CC       (ODAs) in the sperm flagellum. Produces force towards the minus ends of
CC       microtubules. Dynein has ATPase activity; the force-producing power
CC       stroke is thought to occur on release of ADP (Probable). Plays a major
CC       role in sperm motility, implicated in sperm flagellar assembly and
CC       beating (PubMed:31178125). {ECO:0000269|PubMed:31178125,
CC       ECO:0000305|PubMed:31178125}.
CC   -!- SUBUNIT: Consists of at least two heavy chains and a number of
CC       intermediate and light chains.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, flagellum axoneme
CC       {ECO:0000269|PubMed:31178125}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UFH2-1; Sequence=Displayed;
CC       Name=4;
CC         IsoId=Q9UFH2-4; Sequence=VSP_032109, VSP_032110, VSP_032111;
CC   -!- TISSUE SPECIFICITY: Expressed in testis (PubMed:9545504). Expressed in
CC       spermatozoa (at protein level). Not detected in airway epithelial cells
CC       (at protein level) (PubMed:31178125). {ECO:0000269|PubMed:31178125,
CC       ECO:0000269|PubMed:9545504}.
CC   -!- DEVELOPMENTAL STAGE: Expression is detected in the germ cells from the
CC       early spermatocyte to late spermatid stages but not in the somatic
CC       cells (Leydig, Sertoli cells). {ECO:0000269|PubMed:31178125}.
CC   -!- DOMAIN: Dynein heavy chains probably consist of an N-terminal stem
CC       (which binds cargo and interacts with other dynein components), and the
CC       head or motor domain. The motor contains six tandemly-linked AAA
CC       domains in the head, which form a ring. A stalk-like structure (formed
CC       by two of the coiled coil domains) protrudes between AAA 4 and AAA 5
CC       and terminates in a microtubule-binding site. A seventh domain may also
CC       contribute to this ring; it is not clear whether the N-terminus or the
CC       C-terminus forms this extra domain. There are four well-conserved and
CC       two non-conserved ATPase sites, one per AAA domain. Probably only one
CC       of these (within AAA 1) actually hydrolyzes ATP, the others may serve a
CC       regulatory function (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Spermatogenic failure 39 (SPGF39) [MIM:618643]: An autosomal
CC       recessive infertility disorder characterized by
CC       asthenoteratozoospermia. Spermatozoa exhibit multiple morphologic
CC       anomalies including short, absent, irregularly shaped and coiled
CC       flagella, and abnormalities of the head and midpiece.
CC       {ECO:0000269|PubMed:31178125}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 1]: Gene prediction based on partial mRNA data.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the dynein heavy chain family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA04165.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAB59252.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC016182; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC061992; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK097776; BAC05170.1; -; mRNA.
DR   EMBL; BC105107; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z83799; CAB06053.1; -; mRNA.
DR   EMBL; AL122077; CAB59252.1; ALT_INIT; mRNA.
DR   EMBL; AJ000522; CAA04165.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS11757.2; -. [Q9UFH2-1]
DR   PIR; T34558; T34558.
DR   RefSeq; NP_775899.3; NM_173628.3. [Q9UFH2-1]
DR   SMR; Q9UFH2; -.
DR   IntAct; Q9UFH2; 5.
DR   MINT; Q9UFH2; -.
DR   STRING; 9606.ENSP00000374490; -.
DR   GlyGen; Q9UFH2; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q9UFH2; -.
DR   PhosphoSitePlus; Q9UFH2; -.
DR   BioMuta; DNAH17; -.
DR   DMDM; 172044714; -.
DR   EPD; Q9UFH2; -.
DR   jPOST; Q9UFH2; -.
DR   MassIVE; Q9UFH2; -.
DR   MaxQB; Q9UFH2; -.
DR   PaxDb; Q9UFH2; -.
DR   PeptideAtlas; Q9UFH2; -.
DR   ProteomicsDB; 84185; -. [Q9UFH2-1]
DR   ProteomicsDB; 84188; -. [Q9UFH2-4]
DR   Antibodypedia; 19739; 17 antibodies from 12 providers.
DR   DNASU; 8632; -.
DR   Ensembl; ENST00000389840.7; ENSP00000374490.6; ENSG00000187775.17. [Q9UFH2-1]
DR   GeneID; 8632; -.
DR   KEGG; hsa:8632; -.
DR   MANE-Select; ENST00000389840.7; ENSP00000374490.6; NM_173628.4; NP_775899.3.
DR   UCSC; uc010dhp.2; human. [Q9UFH2-1]
DR   AGR; HGNC:2946; -.
DR   CTD; 8632; -.
DR   DisGeNET; 8632; -.
DR   GeneCards; DNAH17; -.
DR   HGNC; HGNC:2946; DNAH17.
DR   HPA; ENSG00000187775; Group enriched (brain, retina, testis).
DR   MalaCards; DNAH17; -.
DR   MIM; 610063; gene.
DR   MIM; 618643; phenotype.
DR   neXtProt; NX_Q9UFH2; -.
DR   OpenTargets; ENSG00000187775; -.
DR   Orphanet; 276234; Non-syndromic male infertility due to sperm motility disorder.
DR   VEuPathDB; HostDB:ENSG00000187775; -.
DR   eggNOG; KOG3595; Eukaryota.
DR   GeneTree; ENSGT00940000154076; -.
DR   InParanoid; Q9UFH2; -.
DR   OMA; MTRNFLS; -.
DR   OrthoDB; 166463at2759; -.
DR   PhylomeDB; Q9UFH2; -.
DR   TreeFam; TF316836; -.
DR   PathwayCommons; Q9UFH2; -.
DR   SignaLink; Q9UFH2; -.
DR   SIGNOR; Q9UFH2; -.
DR   ChiTaRS; DNAH17; human.
DR   Pharos; Q9UFH2; Tdark.
DR   PRO; PR:Q9UFH2; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9UFH2; protein.
DR   Bgee; ENSG00000187775; Expressed in C1 segment of cervical spinal cord and 111 other tissues.
DR   ExpressionAtlas; Q9UFH2; baseline and differential.
DR   Genevisible; Q9UFH2; HS.
DR   GO; GO:0005858; C:axonemal dynein complex; NAS:UniProtKB.
DR   GO; GO:0005930; C:axoneme; IDA:UniProtKB.
DR   GO; GO:0030286; C:dynein complex; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0031514; C:motile cilium; IBA:GO_Central.
DR   GO; GO:0036157; C:outer dynein arm; IDA:UniProtKB.
DR   GO; GO:0036126; C:sperm flagellum; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045505; F:dynein intermediate chain binding; IEA:InterPro.
DR   GO; GO:0051959; F:dynein light intermediate chain binding; IEA:InterPro.
DR   GO; GO:0003777; F:microtubule motor activity; NAS:UniProtKB.
DR   GO; GO:0008569; F:minus-end-directed microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0003341; P:cilium movement; IBA:GO_Central.
DR   GO; GO:0060285; P:cilium-dependent cell motility; NAS:UniProtKB.
DR   GO; GO:0036158; P:outer dynein arm assembly; IDA:UniProtKB.
DR   Gene3D; 1.10.287.2620; -; 1.
DR   Gene3D; 1.10.472.130; -; 1.
DR   Gene3D; 1.10.8.1220; -; 1.
DR   Gene3D; 1.10.8.710; -; 1.
DR   Gene3D; 1.20.1270.280; -; 1.
DR   Gene3D; 1.20.58.1120; -; 1.
DR   Gene3D; 1.20.920.20; -; 1.
DR   Gene3D; 1.20.920.30; -; 1.
DR   Gene3D; 3.10.490.20; -; 1.
DR   Gene3D; 6.10.140.1060; -; 1.
DR   Gene3D; 1.20.140.100; Dynein heavy chain, N-terminal domain 2; 1.
DR   Gene3D; 3.20.180.20; Dynein heavy chain, N-terminal domain 2; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 5.
DR   Gene3D; 1.10.8.720; Region D6 of dynein motor; 1.
DR   InterPro; IPR035699; AAA_6.
DR   InterPro; IPR035706; AAA_9.
DR   InterPro; IPR041658; AAA_lid_11.
DR   InterPro; IPR042219; AAA_lid_11_sf.
DR   InterPro; IPR026983; DHC_fam.
DR   InterPro; IPR041589; DNAH3_AAA_lid_1.
DR   InterPro; IPR042222; Dynein_2_N.
DR   InterPro; IPR043157; Dynein_AAA1S.
DR   InterPro; IPR041466; Dynein_AAA5_ext.
DR   InterPro; IPR041228; Dynein_C.
DR   InterPro; IPR043160; Dynein_C_barrel.
DR   InterPro; IPR024743; Dynein_HC_stalk.
DR   InterPro; IPR024317; Dynein_heavy_chain_D4_dom.
DR   InterPro; IPR004273; Dynein_heavy_D6_P-loop.
DR   InterPro; IPR013602; Dynein_heavy_linker.
DR   InterPro; IPR013594; Dynein_heavy_tail.
DR   InterPro; IPR042228; Dynein_linker_3.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR45703:SF4; DYNEIN AXONEMAL HEAVY CHAIN 17; 1.
DR   PANTHER; PTHR45703; DYNEIN HEAVY CHAIN; 1.
DR   Pfam; PF12774; AAA_6; 1.
DR   Pfam; PF12775; AAA_7; 1.
DR   Pfam; PF12780; AAA_8; 1.
DR   Pfam; PF12781; AAA_9; 1.
DR   Pfam; PF17857; AAA_lid_1; 1.
DR   Pfam; PF18198; AAA_lid_11; 1.
DR   Pfam; PF08385; DHC_N1; 1.
DR   Pfam; PF08393; DHC_N2; 1.
DR   Pfam; PF17852; Dynein_AAA_lid; 1.
DR   Pfam; PF18199; Dynein_C; 1.
DR   Pfam; PF03028; Dynein_heavy; 1.
DR   Pfam; PF12777; MT; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Cilium; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Disease variant; Dynein; Flagellum; Microtubule;
KW   Motor protein; Nucleotide-binding; Reference proteome; Repeat; TPR repeat.
FT   CHAIN           1..4462
FT                   /note="Dynein axonemal heavy chain 17"
FT                   /id="PRO_0000323749"
FT   REPEAT          1019..1052
FT                   /note="TPR 1"
FT   REPEAT          1702..1736
FT                   /note="TPR 2"
FT   REPEAT          4147..4182
FT                   /note="TPR 3"
FT   REGION          1..1808
FT                   /note="Stem"
FT                   /evidence="ECO:0000250"
FT   REGION          1809..2030
FT                   /note="AAA 1"
FT                   /evidence="ECO:0000250"
FT   REGION          2090..2311
FT                   /note="AAA 2"
FT                   /evidence="ECO:0000250"
FT   REGION          2417..2665
FT                   /note="AAA 3"
FT                   /evidence="ECO:0000250"
FT   REGION          2763..3012
FT                   /note="AAA 4"
FT                   /evidence="ECO:0000250"
FT   REGION          3027..3313
FT                   /note="Stalk"
FT                   /evidence="ECO:0000250"
FT   REGION          3405..3632
FT                   /note="AAA 5"
FT                   /evidence="ECO:0000250"
FT   REGION          3842..4068
FT                   /note="AAA 6"
FT                   /evidence="ECO:0000250"
FT   COILED          3027..3086
FT                   /evidence="ECO:0000255"
FT   COILED          3257..3309
FT                   /evidence="ECO:0000255"
FT   BINDING         1847..1854
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         2128..2135
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         2455..2462
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         2801..2808
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..298
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032109"
FT   VAR_SEQ         845..864
FT                   /note="ENAELFRADTLSLPWKDYVI -> VRKHPGGFLRTHLLLAGRRE (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032110"
FT   VAR_SEQ         865..4462
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032111"
FT   VARIANT         431..4462
FT                   /note="Missing (in SPGF39)"
FT                   /evidence="ECO:0000269|PubMed:31178125"
FT                   /id="VAR_083232"
FT   VARIANT         492
FT                   /note="D -> N (in dbSNP:rs34868091)"
FT                   /id="VAR_039581"
FT   VARIANT         792
FT                   /note="I -> V (in dbSNP:rs16971526)"
FT                   /id="VAR_062178"
FT   VARIANT         963
FT                   /note="I -> T (in dbSNP:rs11651537)"
FT                   /id="VAR_062179"
FT   VARIANT         1829
FT                   /note="C -> Y (in SPGF39; loss of the outer dynein arms in
FT                   sperm cells; dbSNP:rs1598595659)"
FT                   /evidence="ECO:0000269|PubMed:31178125"
FT                   /id="VAR_083233"
FT   VARIANT         1972
FT                   /note="M -> V (in dbSNP:rs1462210081)"
FT                   /id="VAR_062180"
FT   VARIANT         3496
FT                   /note="V -> VLDPV (in SPGF39; loss of the outer dynein arms
FT                   in sperm cells)"
FT                   /evidence="ECO:0000269|PubMed:31178125"
FT                   /id="VAR_083234"
FT   VARIANT         3499
FT                   /note="P -> L (in SPGF39; when associated in cis with
FT                   P-3595; not expressed in flagellum and loss of the outer
FT                   dynein arms in sperm cells when associated in cis with
FT                   P-3595; dbSNP:rs1598474055)"
FT                   /evidence="ECO:0000269|PubMed:31178125"
FT                   /id="VAR_083235"
FT   VARIANT         3595
FT                   /note="L -> P (in SPGF39; when associated in cis with
FT                   L-3499; not expressed in flagellum and loss of the outer
FT                   dynein arms in sperm cells when associated in cis with
FT                   L-3499; dbSNP:rs1418782829)"
FT                   /evidence="ECO:0000269|PubMed:31178125"
FT                   /id="VAR_083236"
FT   CONFLICT        732
FT                   /note="K -> N (in Ref. 2; BAC05170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        779
FT                   /note="Q -> H (in Ref. 2; BAC05170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1861..1863
FT                   /note="GRA -> DRP (in Ref. 4; CAB06053)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1910
FT                   /note="S -> Y (in Ref. 4; CAB06053)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1929
FT                   /note="A -> K (in Ref. 4; CAB06053)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1938..1940
FT                   /note="GLI -> SLV (in Ref. 4; CAB06053)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3478
FT                   /note="I -> T (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3496
FT                   /note="V -> A (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3615
FT                   /note="A -> T (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3953
FT                   /note="H -> R (in Ref. 5; CAB59252)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3958
FT                   /note="S -> R (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3967
FT                   /note="S -> R (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3999
FT                   /note="H -> Y (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4003
FT                   /note="H -> Y (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4331
FT                   /note="F -> L (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4414
FT                   /note="D -> A (in Ref. 6; CAA04165)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   4462 AA;  509313 MW;  AEDDF56145E1F2A8 CRC64;
     MTMAPDVRLE YLEEVASIVL KFKPDKWSKL IGAEENVALF TEFFEKPDVQ VLVLTLNAAG
     MIIPCLGFPQ SLKSKGVYFI KTKSENINKD NYRARLLYGD ISPTPVDQLI AVVEEVLSSL
     LNQSENMAGW PQVVSEDIVK QVHRLKNEMF VMSGKIKGKT LLPIPEHLGS LDGTLESMER
     IPSSLDNLLL HAIETTIIDW SHQIRDVLSK DSAQALLDGL HPLPQVEFEF WDTRLLNLKC
     IHEQLNRPKV NKIVEILEKA KSCYWPALQN VYTNVTEGLK EANDIVLYLK PLRILLEEME
     QADFTMLPTF IAKVLDTICF IWATSEYYNT PARIIVILQE FCNQIIEMTR TFLSPEEVLK
     GLQGEIEEVL SGISLAVNVL KELYQTYDFC CVNMKLFFKD KEPVPWEFPS SLAFSRINSF
     FQRIQTIEEL YKTAIEFLKL EKIELGGVRG NLLGSLVTRI YDEVFELVKV FADCKYDPLD
     PGDSNFDRDY ADFEIKIQDL DRRLATIFCQ GFDDCSCIKS SAKLLYMCGG LMERPLILAE
     VAPRYSVMLE LFDAELDNAK ILYDAQMAAS EEGNIPLIHK NMPPVAGQLK WSLELQERLE
     VSMKHLKHVE HPVMSGAEAK LTYQKYDEMM ELLRCHREKI YQQWVAGVDQ DCHFNLGQPL
     ILRDAASNLI HVNFSKALVA VLREVKYLNF QQQKEIPDSA ESLFSENETF RKFVGNLELI
     VGWYNEIKTI VKAVEFLLIK SELEAIDVKL LSAETTLFWN GEGVFQYIQE VREILHNLQN
     RMQKAKQNIE GISQAMKDWS ANPLFERKDN KKEALLDLDG RIANLNKRYA AVRDAGVKIQ
     AMVAENAELF RADTLSLPWK DYVIYIDDMV LDEFDQFIRK SLSFLMDNMV IDESIAPLFE
     IRMELDEDGL TFNPTLEVGS DRGFLALIEG LVNDIYNVAR LIPRLAKDRM NYKMDLEDNT
     DLIEMREEVS SLVINAMKEA EEYQDSFERY SYLWTDNLQE FMKNFLIYGC AVTAEDLDTW
     TDDTIPKTPP TLAQFQEQID SYEKLYEEVS KCENTKVFHG WLQCDCRPFK QALLSTIRRW
     GFMFKRHLSN HVTNSLADLE AFMKVARMGL TKPLKEGDYD GLVEVMGHLM KVKERQAATD
     NMFEPLKQTI ELLKTYGEEM PEEIHLKLQE LPEHWANTKK LAIQVKLTVA PLQANEVSIL
     RRKCQQFELK QHEFRERFRR EAPFSFSDPN PYKSLNKQQK SISAMEGIME ALSKSGGLFE
     VPVPDYKQLK ACHREVRLLK ELWDMVVVVN TSIEDWKTTK WKDINVEQMD IDCKKFAKDM
     RSLDKEMKTW DAFVGLDNTV KNVITSLRAV SELQNPAIRE RHWQQLMQAT QVKFKMSEET
     TLADLLQLNL HSYEDEVRNI VDKAVKESGM EKVLKALDST WSMMEFQHEP HPRTGTMMLK
     SSEVLVETLE DNQVQLQNLM MSKYLAHFLK EVTSWQQKLS TADSVISIWF EVQRTWSHLE
     SIFIGSEDIR TQLPGDSQRF DDINQEFKAL MEDAVKTPNV VEATSKPGLY NKLEALKKSL
     AICEKALAEY LETKRLAFPR FYFVSSADLL DILSNGNDPV EVSRHLSKLF DSLCKLKFRL
     DASDKPLKVG LGMYSKEDEY MVFDQECDLS GQVEVWLNRV LDRMCSTLRH EIPEAVVTYE
     EKPREQWILD YPAQVALTCT QIWWTTEVGL AFARLEEGYE NAIRDYNKKQ ISQLNVLITL
     LMGNLNAGDR MKIMTICTID VHARDVVAKM IVAKVESSQA FTWQAQLRHR WDEEKRHCFA
     NICDAQIQYS YEYLGNTPRL VITPLTDRCY ITLTQSLHLI MGGAPAGPAG TGKTETTKDL
     GRALGTMVYV FNCSEQMDYK SCGNIYKGLA QTGAWGCFDE FNRISVEVLS VIAVQVKCVQ
     DAIRAKKKAF NFLGEIIGLI PTVGIFITMN PGYAGRAELP ENLKALFRPC AMVVPDFELI
     CEIMLMAEGF LEARLLARKF ITLYTLCKEL LSKQDHYDWG LRAIKSVLVV AGSLKRGDPS
     RAEDQVLMRA LRDFNIPKIV TDDLPVFMGL IGDLFPALDV PRKRDLNFEK IIKQSIVELK
     LQAEDSFVLK VVQLEELLQV RHSVFIVGNA GSGKSQVLKS LNKTYQNLKR KPVAVDLDPK
     AVTCDELFGI INPVTREWKD GLFSTIMRDL ANITHDGPKW IILDGDIDPM WIESLNTVMD
     DNKVLTLASN ERIPLNRTMR LVFEISHLRT ATPATVSRAG ILYINPADLG WNPVVSSWIE
     RRKVQSEKAN LMILFDKYLP TCLDKLRFGF KKITPVPEIT VIQTILYLLE CLLTEKTVPP
     DSPRELYELY FVFTCFWAFG GAMFQDQLVD YRVEFSKWWI NEFKTIKFPS QGTIFDYYID
     PDTKKFLPWT DKVPSFELDP DVPLQASLVH TTETIRIRYF MDLLMEKSWP VMLVGNAGTG
     KSVLMGDKLE SLNTDNYLVQ AVPFNFYTTS AMLQGVLEKP LEKKSGRNYG PPGTKKLVYF
     IDDMNMPEVD KYGTVAPHTL IRQHMDHRHW YDRHKLTLKD IHNCQYVACM NPTSGSFTID
     SRLQRHFCVF AVSFPGQEAL TTIYNTILTQ HLAFRSVSMA IQRISSQLVA AALALHQKIT
     ATFLPTAIKF HYVFNLRDLS NIFQGLLFST AEVLKTPLDL VRLWLHETER VYGDKMVDEK
     DQETLHRVTM ASTKKFFDDL GDELLFAKPN IFCHFAQGIG DPKYVPVTDM APLNKLLVDV
     LDSYNEVNAV MNLVLFEDAV AHICRINRIL ESPRGNALLV GVGGSGKQSL SRLAAYISGL
     DVFQITLKKG YGIPDLKIDL AAQYIKAAVK NVPSVFLMTD SQVAEEQFLV LINDLLASGE
     IPGLFMEDEV ENIISSMRPQ VKSLGMNDTR ETCWKFFIEK VRRQLKVILC FSPVGSVLRV
     RARKFPAVVN CTAIDWFHEW PEDALVSVSA RFLEETEGIP WEVKASISFF MSYVHTTVNE
     MSRVYLATER RYNYTTPKTF LEQIKLYQNL LAKKRTELVA KIERLENGLM KLQSTASQVD
     DLKAKLAIQE AELKQKNESA DQLIQVVGIE AEKVSKEKAI ADQEEVKVEV INKNVTEKQK
     ACETDLAKAE PALLAAQEAL DTLNKNNLTE LKSFGSPPDA VVNVTAAVMI LTAPGGKIPK
     DKSWKAAKIM MGKVDTFLDS LKKFDKEHIP EACLKAFKPY QGNPTFDPEF IRSKSTAAAG
     LCSWCINIVR FYEVYCDVAP KRQALEEANA ELAEAQEKLS RIKNKIAELN ANLSNLTSAF
     EKATAEKIKC QQEADATNRV ILLANRLVGG LASENIRWAE SVENFRSQGV TLCGDVLLIS
     AFVSYVGYFT KKYRNELMEK FWIPYIHNLK VPIPITNGLD PLSLLTDDAD VATWNNQGLP
     SDRMSTENAT ILGNTERWPL IVDAQLQGIK WIKNKYRSEL KAIRLGQKSY LDVIEQAISE
     GDTLLIENIG ETVDPVLDPL LGRNTIKKGK YIKIGDKEVE YHPKFRLILH TKYFNPHYKP
     EMQAQCTLIN FLVTRDGLED QLLAAVVAKE RPDLEQLKAN LTKSQNEFKI VLKELEDSLL
     ARLSAASGNF LGDTALVENL ETTKHTASEI EEKVVEAKIT EVKINEAREN YRPAAERASL
     LYFILNDLNK INPVYQFSLK AFNVVFEKAI QRTTPANEVK QRVINLTDEI TYSVYMYTAR
     GLFERDKLIF LAQVTFQVLS MKKELNPVEL DFLLRFPFKA GVVSPVDFLQ HQGWGGIKAL
     SEMDEFKNLD SDIEGSAKRW KKLVESEAPE KEIFPKEWKN KTALQKLCMV RCLRPDRMTY
     AIKNFVEEKM GSKFVEGRSV EFSKSYEESS PSTSIFFILS PGVDPLKDVE ALGKKLGFTI
     DNGKLHNVSL GQGQEVVAEN ALDVAAEKGH WVILQNIHLV ARWLGTLDKK LEHYSTGSHE
     DYRVFISAEP APSPETHIIP QGILENAIKI TNEPPTGMHA NLHKALDLFT QDTLEMCTKE
     MEFKCMLFAL CYFHAVVAER RKFGAQGWNR SYPFNNGDLT ISINVLYNYL EANPKVPWDD
     LRYLFGEIMY GGHITDDWDR RLCRTYLAEY IRTEMLEGDV LLAPGFQIPP NLDYKGYHEY
     IDENLPPESP YLYGLHPNAE IGFLTVTSEK LFRTVLEMQP KETDSGAGTG VSREEKVKAV
     LDDILEKIPE TFNMAEIMAK AAEKTPYVVV AFQECERMNI LTNEMRRSLK ELNLGLKGEL
     TITTDVEDLS TALFYDTVPD TWVARAYPSM MGLAAWYADL LLRIRELEAW TTDFALPTTV
     WLAGFFNPQS FLTAIMQSMA RKNEWPLDKM CLSVEVTKKN REDMTAPPRE GSYVYGLFME
     GARWDTQTGV IAEARLKELT PAMPVIFIKA IPVDRMETKN IYECPVYKTR IRGPTYVWTF
     NLKTKEKAAK WILAAVALLL QV
//
